These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 11732398)

  • 21. [[Prescriptions for psychotropic drugs: results and comments on the 2007 prescription drug report].
    Fritze J
    Nervenarzt; 2008 Nov; 79(11):1337-45. PubMed ID: 19002733
    [No Abstract]   [Full Text] [Related]  

  • 22. [Prescriptions for psychotropic drugs: results and comments on the 2005 prescription drug report].
    Fritze J
    Nervenarzt; 2006 Mar; 77(3):376-83. PubMed ID: 17078120
    [No Abstract]   [Full Text] [Related]  

  • 23. [Total savings effect up to 3 billions Euro].
    Schlander M
    MMW Fortschr Med; 2006 Apr; 148(17):57. PubMed ID: 16711491
    [No Abstract]   [Full Text] [Related]  

  • 24. [More than "cheap copies". Generic drugs promote medical progress].
    MMW Fortschr Med; 2004 Jun; 146(24):51. PubMed ID: 15366498
    [No Abstract]   [Full Text] [Related]  

  • 25. Drug importation and safety of drugs obtained from Canada.
    Shepherd M
    Ann Pharmacother; 2007 Jul; 41(7):1288-91. PubMed ID: 17578879
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Scope of the contract for drug therapy. Rebate contracts also for original drugs].
    MMW Fortschr Med; 2009 Jul; 151(30-33):80. PubMed ID: 19722473
    [No Abstract]   [Full Text] [Related]  

  • 27. WHO must defend patients' interests, not industry.
    Cawthorne P; Ford N; Limpananont J; Tienudom N; Purahong W
    Lancet; 2007 Mar; 369(9566):974-5. PubMed ID: 17382809
    [No Abstract]   [Full Text] [Related]  

  • 28. Potential savings from increased use of generic drugs in the elderly: what the experience of Medicaid and other insurance programs means for a Medicare drug benefit.
    Fischer MA; Avorn J
    Pharmacoepidemiol Drug Saf; 2004 Apr; 13(4):207-14. PubMed ID: 15255087
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 340B program presents opportunities--and challenges.
    Keough CL; Webster SA
    Healthc Financ Manage; 2009 Nov; 63(11):42-4, 46, 48. PubMed ID: 19891397
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [For the first time a health insurance company publishes drug data. Surprise: the thriftiest colleagues are in the East].
    Schmidt K
    MMW Fortschr Med; 2001 Nov; 143(44):53. PubMed ID: 11732399
    [No Abstract]   [Full Text] [Related]  

  • 31. Statin utilisation--recognising the role of the invisible hand.
    Minhas R
    Int J Clin Pract; 2007 Jan; 61(1):3-6. PubMed ID: 17229171
    [No Abstract]   [Full Text] [Related]  

  • 32. [Prescription of generic preparations].
    Ingerslev N
    Ugeskr Laeger; 1993 Jan; 155(4):253-4. PubMed ID: 8430476
    [No Abstract]   [Full Text] [Related]  

  • 33. [Discount for only one drug of the same group leads to impaired health care quality].
    Bergström R
    Lakartidningen; 2006 Feb 8-14; 103(6):387-8; discussion 388. PubMed ID: 16536044
    [No Abstract]   [Full Text] [Related]  

  • 34. Pharmaceutical supply chain in China: current issues and implications for health system reform.
    Yu X; Li C; Shi Y; Yu M
    Health Policy; 2010 Sep; 97(1):8-15. PubMed ID: 20307912
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Cheap drugs with expensive health consequences].
    Milerad J
    Lakartidningen; 2008 Jan 30-Feb 5; 105(5):264. PubMed ID: 18368952
    [No Abstract]   [Full Text] [Related]  

  • 36. Pharmacies receiving massive rebates from generic drug-makers.
    Silversides A
    CMAJ; 2006 Aug; 175(4):342. PubMed ID: 16908889
    [No Abstract]   [Full Text] [Related]  

  • 37. Pricing of drugs with heterogeneous health insurance coverage.
    Ferrara I; Missios P
    J Health Econ; 2012 Mar; 31(2):440-56. PubMed ID: 22484368
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Health insurance discount contracts: problems and risks for the general practitioner in the medical care of patients with chronic illness].
    Leutgeb R; Mahler C; Laux G; Weschnetz A; Szecsenyi J
    Dtsch Med Wochenschr; 2009 Jan; 134(5):181-6. PubMed ID: 19180404
    [TBL] [Abstract][Full Text] [Related]  

  • 39. TRIPS, pharmaceutical patents, and access to essential medicines: a long way from Seattle to Doha.
    't Hoen E
    Chic J Int Law; 2002; 3(1):27-46. PubMed ID: 15709298
    [No Abstract]   [Full Text] [Related]  

  • 40. [Reference prices].
    Rey Abella ME
    Aten Primaria; 1999 Sep; 24(5):252-4. PubMed ID: 10590555
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.